Literature DB >> 7581272

Complement resistance is a virulence factor of Branhamella (Moraxella) catarrhalis.

C Hol1, C M Verduin, E E Van Dijke, J Verhoef, A Fleer, H van Dijk.   

Abstract

The purpose of this study was to investigate complement resistance in Branhamella (Moraxella) catarrhalis isolated from healthy schoolchildren or sputum-producing adult patients. Two techniques were used: a serum bactericidal assay as the gold standard and an easier 'culture and spot' test. Children (age 4-13; n = 303) and patients (n = 1047) showed high colonization/infection rates with B. catarrhalis (31% and 19%, respectively). Complement resistance or intermediate sensitivity occurred frequently in patient isolates (62% and 27%, respectively) and less often in children (33% and 8.5%, respectively; P << 0.0001). In young children (age 4-5 years), the proportion of complement-resistant strains was around 50%. Complement resistance in B. catarrhalis is associated with illness and may hence be considered a virulence factor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7581272     DOI: 10.1111/j.1574-695X.1995.tb00118.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  21 in total

1.  Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.

Authors:  Franz-Josef Schmitz; Andreas Beeck; Mirella Perdikouli; Mechthild Boos; Susanne Mayer; Sybille Scheuring; Karl Köhrer; Jan Verhoef; Ad C Fluit
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Pneumococcal vaccination does not affect the genetic diversity of Moraxella catarrhalis isolates in children.

Authors:  J P Hays; K Eadie; R Veenhoven; C M Verduin; H Verbrugh; A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10       Impact factor: 3.267

3.  A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Authors:  Daniel E Fenker; Cameron T McDaniel; Warunya Panmanee; Ralph J Panos; Eric J Sorscher; Carleen Sabusap; John P Clancy; Daniel J Hassett
Journal:  Int J Respir Pulm Med       Date:  2018-11-29

4.  Identification and characterization of a novel outer membrane protein (OMP J) of Moraxella catarrhalis that exists in two major forms.

Authors:  John P Hays; Saskia van Selm; Theo Hoogenboezem; Silvia Estevão; Kimberly Eadie; Peter van Veelen; Jan Tommassen; Alex van Belkum; Peter W M Hermans
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

5.  Phage antibodies obtained by competitive selection on complement-resistant Moraxella (Branhamella) catarrhalis recognize the high-molecular-weight outer membrane protein.

Authors:  E Boel; H Bootsma; J de Kruif; M Jansze; K L Klingman; H van Dijk; T Logtenberg
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

6.  Serum resistance in an invasive, nontypeable Haemophilus influenzae strain.

Authors:  B J Williams; G Morlin; N Valentine; A L Smith
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

7.  Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2.

Authors:  Thuan Tong Tan; Jens Jørgen Christensen; Morten Hanefeld Dziegiel; Arne Forsgren; Kristian Riesbeck
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

8.  Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis.

Authors:  H J Bootsma; H van Dijk; J Verhoef; A Fleer; F R Mooi
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

9.  Identification of a 3-deoxy-D-manno-octulosonic acid biosynthetic operon in Moraxella catarrhalis and analysis of a KdsA-deficient isogenic mutant.

Authors:  Nicole R Luke; Simon Allen; Bradford W Gibson; Anthony A Campagnari
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

10.  Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade.

Authors:  Ahmed S Attia; Sanjay Ram; Peter A Rice; Eric J Hansen
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.